Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009-2019).

Sabina Sheppard-OlivaresNora M BelloChad M JohannesSamuel E HockerBarbara BillerBrian HusbandsElizabeth SnyderMattison McMillanTalon McKeeRaelene M Wouda

Published in: Veterinary record open (2022)

Most dogs diagnosed with insulinoma and receiving toceranib appeared to have a clinical benefit. Randomised, prospective studies are needed to better elucidate and objectively quantify the potential effect and survival benefit of toceranib therapy for management of insulinoma in dogs.

Keyphrases

clinical trial
physical activity
open label
study protocol
risk assessment
placebo controlled